Funakoshi A, Tateishi K, Tsuru M, Jimi A, Wakasugi H, Ikeda Y, Kono A
Department of Gastroenterology, National Kyushu Cancer Center, Fukuoka, Japan.
Biochem Biophys Res Commun. 1990 Apr 30;168(2):741-6. doi: 10.1016/0006-291x(90)92384-c.
It has been characterized that cell line QGP-1 derived from human non-functioning pancreatic islet cell tumor produces human pancreastatin. Exponentially growing cultures produced 5.7 fmol of pancreastatin/10(6) cells/hr. Human pancreastatin immunoreactivities in plasma and tumor after xenografting with QGP-1 into nude mouse were 92.7 fmol/ml and 160.2 pmol/g wet weight, respectively. Immunocytochemical study revealed both chromogranin A and pancreastatin immunoreactive cells in the tumor. Gel filtrations of culture medium and tumor extract identified heterogenous molecular forms of PST-LI which eluted as large and smaller molecular species. These results suggest that plasma pancreastatin levels may be useful as a tumor marker of endocrine tumor of the pancreas, and the pancreastatin producing cell line may be useful for studies of the mechanism of secretions and processing of chromogranin A and pancreastatin.
已证实,源自人无功能胰岛细胞瘤的细胞系QGP - 1可产生人胰抑素。处于指数生长期的培养物每小时每10⁶个细胞产生5.7飞摩尔胰抑素。将QGP - 1接种到裸鼠体内后,血浆和肿瘤中的人胰抑素免疫反应性分别为92.7飞摩尔/毫升和160.2皮摩尔/克湿重。免疫细胞化学研究显示肿瘤中存在嗜铬粒蛋白A和胰抑素免疫反应性细胞。对培养基和肿瘤提取物进行凝胶过滤,鉴定出胰抑素免疫反应性物质(PST - LI)的异质分子形式,其以大分子和小分子形式洗脱。这些结果表明,血浆胰抑素水平可能作为胰腺内分泌肿瘤的肿瘤标志物,且产生胰抑素的细胞系可能有助于研究嗜铬粒蛋白A和胰抑素的分泌及加工机制。